✦ LIBER ✦

Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study

✍ Scribed by Mysler, Eduardo F.; Spindler, Alberto J.; Guzman, Renato; Bijl, Marc; Jayne, David; Furie, Richard A.; Houssiau, Frédéric A.; Drappa, Jorn; Close, David; Maciuca, Romeo; Rao, Kajal; Shahdad, Saba; Brunetta, Paul

Book ID: 120989668
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 148 KB
Volume: 65
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.38037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of tapentadol ER for

Efficacy and safety of tapentadol ER for chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

✍ R. Buynak; D. Shapiro; A. Okamoto; I. Van Hove; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Efficacy and safety of oxymorphone exten

Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study

✍ Martin E. Hale; Chris Dvergsten; Joseph Gimbel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Efficacy and safety of rituximab in mode

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

✍ Joan T. Merrill; C. Michael Neuwelt; Daniel J. Wallace; Joseph C. Shanahan; Kevi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

## Abstract ## Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE Evaluation of Rituximab (EXPLORER) trial tested the efficacy and safety of rituximab versus placebo in p

Efficacy and Safety of AMG 853 in Asthma

Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

✍ Busse, W.W.; Wenzel, S.E.; Meltzer, E.O.; Kerwin, E.M.; Liu, M.C.; Zhang, N.; Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Efficacy and Safety of Omalizumab in Chr

Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Casale, Thomas; Maurer, Marcus; Hsieh, Hsin-Ju; Canvin, Janice; Saini, Sarbjit S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB